# Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes

> **NCT07520305** · NA · NOT_YET_RECRUITING · sponsor: **Beijing Chao Yang Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus paracasei LC19 Intervention

## Key facts

- **NCT ID:** NCT07520305
- **Lead sponsor:** Beijing Chao Yang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07520305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07520305, "Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07520305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*